87 results
425
EX-99.1
THER
Theralink Technologies, Inc.
26 May 23
Business combination disclosure
5:14pm
effective treatment plan for their cancer patients.
Recently, Theralink received a Medicare reimbursement rate determination as well as added to its … access and reimbursement initiatives for our clinical patient testing, expand our product offering portfolio and research initiatives, and increase our
425
EX-2.1
fnq5yt6i42dx5jr86w
26 May 23
Business combination disclosure
5:14pm
8-K
EX-99.1
c9qr2 iqu
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
EX-2.1
ung63ho3p8htzpgef226
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
hfn4cq64wx00z6v
11 May 23
Departure of Directors or Certain Officers
5:00pm
8-K
EX-99.1
laqz2v6
8 Dec 22
Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief
7:23pm
8-K
n413kniuf73g4g660
8 Dec 22
Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief
7:23pm
8-K
EX-10.1
mu6trd9 1weir
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.2
legi1rsg
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.1
qz92vm 5rmjpq
3 Feb 22
Entry into a Material Definitive Agreement
5:11pm